From online forums to the clinic, people have reported that diabetes and weight-loss drugs such as Ozempic and Wegovy can ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use ...

Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent the formation of new substance ​use disorders and alleviate ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Study of 600,000 US military veterans shows that those who took anti-obesity medications were less likely to develop some complications of substance-use disorders.

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows. Semaglutide (also known as Ozempic) ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

SPONSORED: Not sure which GLP-1 is right for you? A St. Joseph Health nurse practitioner explains the key differences between ...

Weight-loss jabs could prevent and treat addiction to alcohol, cigarettes and drugs, according to a large study. Experts ...